ODI — Odi Pharma AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK31.83m
- SEK29.83m
- SEK22.29m
Annual cashflow statement for Odi Pharma AB (publ), fiscal year end - June 30th, SEK millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.93 | -3.96 | -7.21 | -6.81 | 0.428 |
| Depreciation | |||||
| Non-Cash Items | 0.131 | 0.035 | 0.05 | 0.707 | -0.089 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.044 | -2.14 | -0.223 | 0.996 | -4.17 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.75 | -6.06 | -7.37 | -5.1 | -3.82 |
| Capital Expenditures | -0.024 | 0 | -0.004 | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.024 | 0 | -0.004 | 0 | 0 |
| Financing Cash Flow Items | -3.7 | 0.259 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20.9 | 0.259 | 0 | 4.06 | 0 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 16.1 | -5.89 | -7.26 | -0.875 | -3.85 |